These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24155157)

  • 41. Pharmacokinetics and distribution of minocycline in mature horses after oral administration of multiple doses and comparison with minimum inhibitory concentrations.
    Schnabel LV; Papich MG; Divers TJ; Altier C; Aprea MS; McCarrel TM; Fortier LA
    Equine Vet J; 2012 Jul; 44(4):453-8. PubMed ID: 21950341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioequivalence study of two minocycline capsule formulations in healthy volunteers.
    Setiawati E; Purnomo A; Deniati SH; Yunaidi DA; Handayani LR; Harinato G; Santoso ID
    Arzneimittelforschung; 2009; 59(10):532-6. PubMed ID: 19998582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of tigecycline on normal oropharyngeal and intestinal microflora.
    Nord CE; Sillerström E; Wahlund E
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3375-80. PubMed ID: 17005820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of tigecycline in turkey plasma by LC-MS/MS: validation and application in a pharmacokinetic study.
    Jasiecka-Mikołajczyk A; Jaroszewski JJ
    Pol J Vet Sci; 2017 Mar; 20(2):241-249. PubMed ID: 28865218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic characteristics of minocycline in debilitated elderly patients.
    Yamamoto T; Takano K; Matsuyama N; Koike Y; Minshita S; Sanaka M; Kuyama Y; Yamakana M
    Am J Ther; 1999 May; 6(3):157-60. PubMed ID: 10423658
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers.
    Wiskirchen DE; Housman ST; Quintiliani R; Nicolau DP; Kuti JL
    Pharmacotherapy; 2013 Mar; 33(3):266-74. PubMed ID: 23400916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli.
    Docobo-Pérez F; Nordmann P; Domínguez-Herrera J; López-Rojas R; Smani Y; Poirel L; Pachón J
    Int J Antimicrob Agents; 2012 Mar; 39(3):251-4. PubMed ID: 22154856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid.
    Wittmann DH; Schassan HH; Kohler F; Seibert W
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():293-7. PubMed ID: 19803001
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjects.
    Muralidharan G; Fruncillo RJ; Micalizzi M; Raible DG; Troy SM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1656-9. PubMed ID: 15793165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of a second-generation tetracycline antibiotic minocycline in human plasma by LC-MS/MS.
    Patel DS; Sharma N; Patel MC; Patel BN; Shrivastav PS; Sanyal M
    Bioanalysis; 2011 Oct; 3(19):2177-94. PubMed ID: 21985413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of a clinically derived exposure-response relationship to evaluate potential tigecycline-Enterobacteriaceae susceptibility breakpoints.
    Ambrose PG; Meagher AK; Passarell JA; Van Wart SA; Cirincione BB; Rubino CM; Korth-Bradley JM; Babinchak T; Ellis-Grosse E
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):38-42. PubMed ID: 19073300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model.
    Zhou J; Ledesma KR; Chang KT; Abodakpi H; Gao S; Tam VH
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tigecycline pharmacokinetic/pharmacodynamic update.
    MacGowan AP
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i11-6. PubMed ID: 18684702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery.
    Gergs U; Clauss T; Ihlefeld D; Weiss M; Pönicke K; Hofmann GO; Neumann J
    J Pharm Pharmacol; 2014 Nov; 66(11):1552-8. PubMed ID: 24941934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
    Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.
    Wei C; Ni W; Cai X; Cui J
    Infect Dis (Lond); 2015; 47(12):846-51. PubMed ID: 26167850
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Saliva and blood concentration of cefuroxime in patients undergoing maxillofacial surgery.
    Venetis G; Chatzika K; Pitsiou G; Kechagias N; Antoniades K; Kioumis IP
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1398-403. PubMed ID: 22459228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.